News | Prostate Cancer | November 01, 2023

Reimbursement code improves access to personalized prostate cancer care with Avenda Health’s AI cancer mapping platform, Unfold AI 

Reimbursement code improves access to personalized prostate cancer care with Avenda Health’s AI cancer mapping platform, Unfold AI

November 1, 2023 — The American Medical Association (AMA) has announced its 2024 Current Procedural Terminology (CPT) code set will include a new Category III code for Avenda Health’s innovative Unfold AI™, a cancer AI platform that creates new clinically meaningful insights to aid physicians and patients in making informed treatment decisions. CPT codes are used to report medical procedures and services for processing claims, conducting research, evaluating utilization and developing medical guidelines. The Category III designation is a temporary code for new and developing technologies. 

The comprehensive description of the new code is: 

X237T- Non-invasive prostate cancer estimation map, derived from augmentative analysis of image-guided fusion biopsy and pathology, including visualization of margin volume and location, with margin determination and physician interpretation and report.  

“This recognition by the CPT Editorial Panel is a testament to our dedication to providing cutting-edge solutions in the field of cancer diagnosis and treatment,” said Dr. Brittany Berry-Pusey, COO and co-founder. “The new CPT code solidifies our position as a frontrunner in revolutionizing cancer care and our commitment to making our technology accessible to all patients.” 

Unfold AI is a decision support platform that provides the physician and the patient with critical information, comprehensive insights, and planning guidance to ensure the patient is put on the right path for their unique cancer journey. By integrating patient-specific data from prostate imaging and biopsies the platform generates a customized cancer probability map using state-of-the-art machine learning. Its 3D, AI-generated map enables physicians to visualize the precise location of cancer for informed intervention planning.  

Avenda Health recently announced Unfold AI’s use by Matthew Allaway, D.O. at Urology Associates in Maryland, leveraging the FDA-cleared technology in their procedures. Avenda plans to expand to major teaching hospitals and urology practices nationwide, ensuring widespread access to advanced cancer care solutions.  

The full set of Category III codes are published annually in the CPT codebook. The most recently approved codes will be posted to the AMA CPT website January 1, 2024 with an effective implementation date of July 1, 2024. 

For more information: avendahealth.com 


Related Content

Feature | Breast Imaging

Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...

Time October 24, 2025
arrow
News | Contrast Media

Oct. 21, 2025 — Subtle Medical, Inc., a provider of AI-powered medical imaging solutions, has announced positive ...

Time October 21, 2025
arrow
News | Artificial Intelligence

Oct. 20, 2025 — Viz.ai has launched of Viz Assist, a suite of autonomous AI agents that significantly enhance how care ...

Time October 20, 2025
arrow
News | CT Angiography (CTA)

Oct. 9, 2025 — RapidAI recently announced that its Lumina 3D built on the Rapid Enterprise Platform has been named to ...

Time October 16, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

Oct. 15, 2025 — GE HealthCare has announced the latest advancement in its Venue family of point-of-care ultrasound ...

Time October 16, 2025
arrow
News | RSNA 2025

Oct. 7, 2025 — RSNA Ventures, a mission-aligned subsidiary of Radiological Society of North America (RSNA), has ...

Time October 08, 2025
arrow
News | RSNA 2025

Oct. 7, 2025 – Clairity Inc., a leader in AI-based breast cancer risk prediction, will make five scientific ...

Time October 07, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Oct. 6, 2025 — Hyperfine, Inc. has launched the Portable Ultra-Low-Field Scientific Exchange (PULSE), a subscription ...

Time October 06, 2025
arrow
News | Mammography

Sept. 26, 2025 — Data from two groundbreaking studies evaluating the performance of Hologic’s artificial intelligence ...

Time October 02, 2025
arrow
News | Prostate Cancer

Sept. 30, 2025 – EDAP TMS's non-invasive, nonsurgical treatment option, Focal One Robotic HIFU, was featured on national ...

Time September 30, 2025
arrow
Subscribe Now